Rondla Rohini,1 P. Muralidhar Reddy,1,2 Kanne Shanker1 and Vadde Ravinder1,*
1 Department of Chemistry, Kakatiya University, Warangal-506 009, A. P., India
2 Department of Chemistry, National DongHwa University, Hualien, Taiwan
* Corresponding author: E-mail: ravichemku@rediffmail.com
Abstract
Some new mono and bis-2,2-(arylidineaminophenyl)benzimidazole derivatives have
been synthesized and characterized
via IR, 1H NMR, 13C NMR, MS and elemental analysis. All the products were
screened for antibacterial activity
against Staphylococcus aureus, Bacillus subtilis, Streptococcus pyogenes,
Salmonella typhimurium, Escherichia coli
and Klebsiella pneumonia and antifungal activity against Aspergillus niger,
Candida albicans and Trichoderma viridae.
Compounds 5, 6 exhibited potent in vitro antibacterial activity against S.
aureus, B. subtilis, S. pyogenes whereas compounds
13–16 exerted superior activity against all tested bacterial and fungal strains
even than standard drugs Ampicillin
and Ketoconazole.
Keywords: 2,2-(arylidineaminophenyl)benzimidazole, synthesis, antibacterial activity, antifungal activity